Investor Overview

NASDAQ: XBIT0.0010.46Data provided by Nasdaq.
Minimum 15 minutes delayed.

XBiotech is building on a foundation of remarkable new therapies, innovative approaches to commercialization and a commitment to realizing treatments for unmet medical needs worldwide.

Recent News
04/20/17XBiotech Announces Outcome of EMA’s Oral Explanation MeetingPrinter Friendly Version
04/10/17XBiotech Announces Additions To Its Scientific Advisory BoardPrinter Friendly Version
04/03/17XBiotech Announces Top-Line Results for 514G3 Antibody Therapy in Serious Staphylococcus aureus InfectionsPrinter Friendly Version

Read more »

Upcoming Events

There are currently no events scheduled.

Read more »